Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction

Betty Sue Pace, Sima Zein

Research output: Contribution to journalReview article

40 Citations (Scopus)

Abstract

The developmental regulation of γ-globin gene expression has shaped research efforts to establish therapeutic modalities for individuals affected with sickle cell disease (SCD). Fetal hemoglobin (Hb F) synthesis is high at birth, followed by a decline to adult levels by 10 months of age. The expression of γ-globin is controlled by a developmentally regulated transcriptional program that is recapitulated during normal erythropoiesis in the adult bone marrow. It is known that naturally occurring mutations in the γ-gene promoters cause persistent Hb F synthesis after birth, which ameliorates symptoms in SCD by inhibiting hemoglobin S polymerization and vaso-occlusion. Several pharmacological agents have been identified over the past 2 decades that reactivate γ-gene transcription through different cellular systems. We will review the progress made in our understanding of molecular mechanisms that control γ-globin expression and insights gained from Hb F-inducing agents that act through signal transduction pathways.

Original languageEnglish (US)
Pages (from-to)1727-1737
Number of pages11
JournalDevelopmental Dynamics
Volume235
Issue number7
DOIs
StatePublished - Jul 1 2006

Fingerprint

Fetal Hemoglobin
Globins
Sickle Cell Anemia
Pharmacology
Developmental Gene Expression Regulation
Parturition
Genes
Sickle Hemoglobin
Erythropoiesis
Polymerization
Signal Transduction
Bone Marrow
Mutation
Research
Therapeutics

Keywords

  • Decitabine
  • Fetal hemoglobin
  • Histone deacetylase inhibitors
  • Hydroxyurea
  • Short chain fatty acids
  • Sickle cell disease
  • cGMP
  • p38 MAPK

ASJC Scopus subject areas

  • Developmental Biology

Cite this

Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction. / Pace, Betty Sue; Zein, Sima.

In: Developmental Dynamics, Vol. 235, No. 7, 01.07.2006, p. 1727-1737.

Research output: Contribution to journalReview article

@article{29394f64ac2b431db332ff5e0d76492b,
title = "Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction",
abstract = "The developmental regulation of γ-globin gene expression has shaped research efforts to establish therapeutic modalities for individuals affected with sickle cell disease (SCD). Fetal hemoglobin (Hb F) synthesis is high at birth, followed by a decline to adult levels by 10 months of age. The expression of γ-globin is controlled by a developmentally regulated transcriptional program that is recapitulated during normal erythropoiesis in the adult bone marrow. It is known that naturally occurring mutations in the γ-gene promoters cause persistent Hb F synthesis after birth, which ameliorates symptoms in SCD by inhibiting hemoglobin S polymerization and vaso-occlusion. Several pharmacological agents have been identified over the past 2 decades that reactivate γ-gene transcription through different cellular systems. We will review the progress made in our understanding of molecular mechanisms that control γ-globin expression and insights gained from Hb F-inducing agents that act through signal transduction pathways.",
keywords = "Decitabine, Fetal hemoglobin, Histone deacetylase inhibitors, Hydroxyurea, Short chain fatty acids, Sickle cell disease, cGMP, p38 MAPK",
author = "Pace, {Betty Sue} and Sima Zein",
year = "2006",
month = "7",
day = "1",
doi = "10.1002/dvdy.20802",
language = "English (US)",
volume = "235",
pages = "1727--1737",
journal = "Developmental Dynamics",
issn = "1058-8388",
publisher = "Wiley-Liss Inc.",
number = "7",

}

TY - JOUR

T1 - Understanding mechanisms of γ-globin gene regulation to develop strategies for pharmacological fetal hemoglobin induction

AU - Pace, Betty Sue

AU - Zein, Sima

PY - 2006/7/1

Y1 - 2006/7/1

N2 - The developmental regulation of γ-globin gene expression has shaped research efforts to establish therapeutic modalities for individuals affected with sickle cell disease (SCD). Fetal hemoglobin (Hb F) synthesis is high at birth, followed by a decline to adult levels by 10 months of age. The expression of γ-globin is controlled by a developmentally regulated transcriptional program that is recapitulated during normal erythropoiesis in the adult bone marrow. It is known that naturally occurring mutations in the γ-gene promoters cause persistent Hb F synthesis after birth, which ameliorates symptoms in SCD by inhibiting hemoglobin S polymerization and vaso-occlusion. Several pharmacological agents have been identified over the past 2 decades that reactivate γ-gene transcription through different cellular systems. We will review the progress made in our understanding of molecular mechanisms that control γ-globin expression and insights gained from Hb F-inducing agents that act through signal transduction pathways.

AB - The developmental regulation of γ-globin gene expression has shaped research efforts to establish therapeutic modalities for individuals affected with sickle cell disease (SCD). Fetal hemoglobin (Hb F) synthesis is high at birth, followed by a decline to adult levels by 10 months of age. The expression of γ-globin is controlled by a developmentally regulated transcriptional program that is recapitulated during normal erythropoiesis in the adult bone marrow. It is known that naturally occurring mutations in the γ-gene promoters cause persistent Hb F synthesis after birth, which ameliorates symptoms in SCD by inhibiting hemoglobin S polymerization and vaso-occlusion. Several pharmacological agents have been identified over the past 2 decades that reactivate γ-gene transcription through different cellular systems. We will review the progress made in our understanding of molecular mechanisms that control γ-globin expression and insights gained from Hb F-inducing agents that act through signal transduction pathways.

KW - Decitabine

KW - Fetal hemoglobin

KW - Histone deacetylase inhibitors

KW - Hydroxyurea

KW - Short chain fatty acids

KW - Sickle cell disease

KW - cGMP

KW - p38 MAPK

UR - http://www.scopus.com/inward/record.url?scp=33745126299&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33745126299&partnerID=8YFLogxK

U2 - 10.1002/dvdy.20802

DO - 10.1002/dvdy.20802

M3 - Review article

VL - 235

SP - 1727

EP - 1737

JO - Developmental Dynamics

JF - Developmental Dynamics

SN - 1058-8388

IS - 7

ER -